Quick Answer
Alto Neuroscience, Inc. reported Net Income of -$63.24 million for fiscal year 2025.
Alto Neuroscience, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$63.24M | -2.9% |
| 2024 | -$61.43M | -69.2% |
| 2023 | -$36.30M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.18M | +15.5% | +19.9% |
| June 30, 2025 | -$17.71M | -10.5% | -16.7% |
| March 31, 2025 | -$15.17M | -13.1% | +9.6% |
| September 30, 2024 | -$16.78M | -83.6% | -4.7% |
| June 30, 2024 | -$16.03M | -85.0% | -19.5% |
| March 31, 2024 | -$13.42M | -84.2% | -46.8% |
| September 30, 2023 | -$9.14M | — | -5.5% |
| June 30, 2023 | -$8.66M | — | -18.9% |
- Alto Neuroscience, Inc. showed a decrease of -2.9% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Alto Neuroscience, Inc.’s net income has declined by 74.2% (from -$36.30 million to -$63.24 million).
- The most recent figure is from Alto Neuroscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: